Aditxt

1D
1W
1M
3M
1Y
5Y

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Aditxt and other ETFs, options, and stocks.

About ADTX

Aditxt, Inc. engages in the development of biotechnologies specifically focused on improving the health of the immune system through immune reprogramming and monitoring. It has a worldwide license for commercializing a nucleic acid-based technology, named Apoptotic DNA Immunotherapy (ADi), which utilizes a novel approach that mimics the way the body naturally induces tolerance to its own tissue. 

CEO
Amro Albanna
CEOAmro Albanna
Employees
58
Employees58
Headquarters
Richmond, Virginia
HeadquartersRichmond, Virginia
Founded
2017
Founded2017
Employees
58
Employees58

ADTX Key Statistics

Market cap
8.02M
Market cap8.02M
Price-Earnings ratio
Price-Earnings ratio
Dividend yield
Dividend yield
Average volume
7.60M
Average volume7.60M
High today
$3.74
High today$3.74
Low today
$3.15
Low today$3.15
Open price
$3.32
Open price$3.32
Volume
3.99M
Volume3.99M
52 Week high
$136.00
52 Week high$136.00
52 Week low
$2.58
52 Week low$2.58

ADTX Earnings

-$48.50
-$32.33
-$16.17
$0.00
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Q1 FY22
Q2 FY22
Q3 FY22
Estimated
per share
Estimated per share
Actual
Expected Nov 14, After Hours
ActualExpected Nov 14, After Hours
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC.